Structures by: Soliman A. M.
Total: 7
2-(1,3-Benzothiazol-2-yl)guanidine
C8H8N4S
Acta Crystallographica Section E (2011) 67, 4 o786
a=10.2970(3)Å b=10.0817(3)Å c=33.5158(11)Å
α=90.00° β=90.00° γ=90.00°
4-(4-Chlorobenzyl)-5-methyl-2-phenyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C17H15ClN2O
Acta Crystallographica Section E (2011) 67, 5 o1153
a=23.1540(3)Å b=43.8905(6)Å c=5.62390(10)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-4-phenyl-4<i>H</i>,10<i>H</i>-1,3,5- triazino[1,2-<i>a</i>]benzimidazol-3-ium chloride
C15H14N5,Cl
Acta Crystallographica Section E (2011) 67, 5 o1154
a=8.6454(5)Å b=9.0440(4)Å c=9.7182(6)Å
α=83.306(4)° β=70.956(5)° γ=81.523(4)°
2-(Piperidin-1-yl)-6-(1<i>H</i>-pyrrol-1-yl)pyridine-3,5-dicarbonitrile
C16H15N5
Acta Crystallographica Section E (2012) 68, 4 o938
a=11.9372(16)Å b=6.6919(8)Å c=17.158(2)Å
α=90° β=92.280(7)° γ=90°
2-(Morpholin-4-yl)-6-(1<i>H</i>-pyrrol-1-yl)pyridine-3,5-dicarbonitrile
C15H13N5O
Acta Crystallographica Section E (2012) 68, 3 o885-o886
a=8.633(2)Å b=8.763(3)Å c=9.559(3)Å
α=91.715(7)° β=108.110(8)° γ=100.572(7)°
2-(1,3-Benzothiazol-2-yl)guanidin-2-ium acetate
C8H9N4S,C2H3O2
Acta Crystallographica Section E (2011) 67, 11 o2920
a=12.596(2)Å b=11.276(2)Å c=8.0936(12)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-6-(dimethylamino)pyridine-3,5-dicarbonitrile
C9H9N5
Acta Crystallographica Section E (2012) 68, 5 o1532
a=28.667(7)Å b=3.9702(10)Å c=17.950(4)Å
α=90.00° β=112.920(3)° γ=90.00°